| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 9.9% | $1,693,423 | 1,007,990 | Stonepine Capital Management, LLC | 19 Dec 2025 | |||
| 683 Capital Management, LLC | 7.9% | $1,510,072 | 770,445 | 683 Capital Management, LLC | 22 Dec 2025 | |||
| FAIRBAIRN EMILY | 7.5% | $1,268,597 | 733,293 | EMILY FAIRBAIRN | 22 Dec 2025 | |||
| Ho William Tai-Wei | 3.7% | $341,764 | 151,223 | William Tai-Wei Ho | 30 Jun 2025 | |||
| Transcend Partners Opportunity Fund I LLC | 2.6% | $242,760 | 107,416 | Transcend Partners Opportunity Fund LLC | 30 Jun 2025 |
As of 30 Sep 2025, 18 institutional investors reported holding 693,655 shares of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB). This represents 7.1% of the company’s total 9,777,240 outstanding shares.